CCI-779 FOR AMPHICYTE LYMPHOMA TREATMENT

摘要

FIELD: medicine. ^ SUBSTANCE: according to the invention, method involves introduction of Paramycin 42 ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779). In addition, the invention refers to applications of CCI-779 in producing a medicinal agent for amphicyte lymphoma. ^ EFFECT: application of the invention ensures amphicyte lymphoma treatment. ^ 9 cl, 3 ex